Company news
Aptevo Therapeutics Inc. news in 2021
Aptevo Therapeutics Inc.'s news releases, calls and decks from 2021, newest first.
Aptevo Therapeutics Announces the Presentation of Two Abstracts at the Upcoming American Society of Hematology Annual Meeting
November 14, 2021
Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
November 11, 2021
Aptevo Therapeutics Announces Preclinical Data for Bispecific Antibody APVO603 at the Society for Immunology in Cancer Annual Meeting
November 10, 2021
Aptevo Therapeutics Announces APVO436 Monotherapy is Active in Patients Who Have Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome
August 16, 2021
Aptevo Therapeutics Reports Second Quarter Financial Results with Business Highlights
August 11, 2021
Aptevo Therapeutics Announces Inclusion in the Russell Microcap(R) Index
June 28, 2021
Aptevo Therapeutics Announces Expansion Phase of Lead Anti-Leukemia Drug APVO436 in Adult Patients with Acute Myeloid Leukemia
May 26, 2021
Aptevo Therapeutics Reports First Quarter 2021 Financial Results
May 10, 2021
Aptevo Therapeutics Reports 2020 Financial Results and Provides Business Update
March 30, 2021
Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial
January 10, 2021